Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.

Artificial organs - 1 Mar 2010

Lisowska Katarzyna A, Debska-Slizien Alicja, Radzka Monika, Witkowski Jacek M, Rutkowski Boleslaw, Bryl Ewa

Abstract excerpt

Patients with chronic renal failure (CRF) receive recombinant human erythropoietin (rhEPO) for the correction of anemia. However, rhEPO also has an immunomodulatory effect. Detailed changes of phenotype and function of CD4(+) T lymphocytes in CRF patients receiving rhEPO have not been reported yet; their study may bring insight into understanding of this immunomodulatory action of rhEPO. Two groups of CRF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Differentiation, T-Lymphocyte
Share to CD28 Antigens

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to CD40 Ligand

Share to Erythropoietin

Share to Immunologic Factors

Share to Kidney Failure, Chronic

Share to Lectins, C-Type

Share to Renal Dialysis

Source

Identifiers

PMID: 20447038
DOI: 10.1111/j.1525-1594.2009.00942.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.PMID 20447038Read ↗

Hemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes.Semantic proximity Read ↗

Phenotype, proliferation and apoptosis of B lymphocytes in hemodialysis patients treated with recombinant human erythropoietin.Semantic proximity Read ↗

T-cell function, T-cell phenotype and its role in responsiveness to recombinant human erythropoietin in hemodialysis patients.Semantic proximity Read ↗

Hemodiafiltration May Be Associated with Senescence-Related Phenotypic Alterations of Lymphocytes Which May Predict Mortality in Dialysis PatientsSemantic proximity Read ↗

Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agentsSemantic proximity Read ↗

Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.Semantic proximity Read ↗

Hemodiafiltration May Be Associated with Senescence-Related Phenotypic Alterations of Lymphocytes, Which May Predict Mortality in Patients Undergoing Dialysis.Semantic proximity Read ↗

Early T Cell Activation Correlates with Expression of Apoptosis Markers in Patients with End-Stage Renal DiseaseSemantic proximity Read ↗

T-cell subpopulation in patients with metastatic renal cell carcinoma treated by recombinant interleukin-2, recombinant interferon-alpha, 5-fluorouracil, and vinblastine.Semantic proximity Read ↗

CD4+CD25+ lymphocyte subsets in chronic graft versus host disease patients undergoing extracorporeal photochemotherapy.Semantic proximity Read ↗

Peripheral Treg count and it's determinants in unsensitized and sensitized chronic kidney disease patients.Semantic proximity Read ↗

Bone marrow-derived endothelial progenitor cells confer renal protection in a murine chronic renal failure model.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.